T cell control of SARS-CoV-2: When, which, and where?

Diniz, Mariana O; Maini, Mala K; Swadling, Leo

Diniz, Mariana O; Maini, Mala K; Swadling, Leo.

Afiliação

Diniz MO; Division of Infection and Immunity, Institute of Immunity and Transplantation, University College London, Pears Building, London WC1E 6BT, UK.
Maini MK; Division of Infection and Immunity, Institute of Immunity and Transplantation, University College London, Pears Building, London WC1E 6BT, UK. Electronic address: m.maini@ucl.ac.uk.
Swadling L; Division of Infection and Immunity, Institute of Immunity and Transplantation, University College London, Pears Building, London WC1E 6BT, UK. Electronic address: l.swadling@ucl.ac.uk.

Semin Immunol ; 70: 101828, 2023 11.

Article em En | MEDLINE | ID: mdl-37651850

Assuntos

COVID-19; SARS-CoV-2; Animais; Humanos; Linfócitos T; Imunidade Humoral; Antivirais; Vacinação; Anticorpos Antivirais

Palavras-chave

Abortive infection; Mucosal vaccination; SARS-CoV-2-specific T cells; Tissue-resident

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Qualitative_research Limite: Animals / Humans Idioma: En Revista: Semin Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google